China CAR-T Cell

16/06/2025

( ):
This medication increases the production of the SMN protein, which is deficient in or . It's approved for both children and adults and administered via lumbar puncture.

Like to know the here in China. Contact us.

14/11/2024

Concerning CRISPER/CAS9 therapy(for SCD/TDT). The strengths compare to other therapies
1. This therapy is likely to be used only once in a lifetime, and the only way to cure it so far.
2. No GVHD risk
3. The risk of infection is similar to that of autologous bone marrow transplantation. We will deal with it and it will be fine as soon as the patient is discharged from the hospital.

09/09/2024

TILs therapy for solid tumors like melanoma, lung cancer, breast cancers, cervical carcinoma & etc.

13/05/2024

More CAR-T centers in China.

In China more & more CAR-T center we build. Come to us for more details about the CAR-T cell therapy & cost;.

04/03/2024

As FUCASO has been approved in China. So the patient with MM & BCMA+. You could choose to visit China for an approved CAR-T treatment.

25/12/2023

You may consider doing CAR-T therapy in China if you are with Relapsed and Refractory blood tumors and the tradtional treatment won't help.

24/12/2023

Merry Xmas!

19/12/2023

A MM patient's story.

If you are with R/R Multiple Myeloma, here the CAR-T here is a choice for you. Send us your medical documents for free opinions.

29/11/2023

Newly approved CAR-T therapy in China. It's for R/R B-ALL & Lymphoma. The cost of the cells is even lower than USD140,000(cell preparation only)

On November 20, “Science and Technology Innovation Board Daily” mentioned in a report that Heyuan Biotechnology’s CAR-T product has just been approved and is priced at CNY999,000/USD140,000, which is currently the lowest priced among domestic approved products. According to the latest report f...

20/11/2023

relapsed and refractory acute lymphoblastic leukemia, CAR-T works on it.

Recently, Grandma Sun, an 80-year-old woman suffering from acute lymphoblastic leukemia, went to the Department of Hematology of the Second Affiliated Hospital of Anyi University for a review as scheduled. The examination report showed that the elderly woman’s condition continues to be in remissio...

27/10/2023

CAR-T therapy the new hope for multiple myeloma patients.

25/10/2023

A patient with DLBCL 85 years old discharged from a hospital in China after CAR-T therapy.

On August 7 2023, a CAR-T cell therapy patient was successfully discharged from the Hematology and Cancer Center of Chongqing University Cancer Hospital. Grandma Li, 85 years old, has become the oldest patient in China to receive CAR-T cell therapy. Five years ago, Grandma Li felt a mass on her left...